COMPANY

Strategikon Pharma

HQ: San Francisco, CA source · clinicalmaestro.com ↗ · West Coast

Location: San Francisco, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $2.29M in debt securities (Form D filed Nov 21, 2025). SEC Form D 0001722200-25-000002 (Nov 21, 2025)
Evidence (1 event)
- Nov 21, 2025 · SEC Form D 0001722200-25-000002
  Name of Issuer: Strategikon Pharma, Inc.; CIK: 1722200; Address: San Francisco, CA; Submission type: D; Filing date: 2025-11-21; Industry Group: Other Technology; Date of First Sale: 2025-05-08; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2291885; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals